论文信息 - Phase 2 Trial of the GPNMB-Targeted Antibody-Drug Conjugate, Glembatumumab Vedotin (CDX-011) in Recurrent Osteosarcoma AOST1521: A Report from the Children’s Oncology Group (COG) - 字舞流文

Phase 2 Trial of the GPNMB-Targeted Antibody-Drug Conjugate, Glembatumumab Vedotin (CDX-011) in Recurrent Osteosarcoma AOST1521: A Report from the Children’s Oncology Group (COG)

R. Randall | J. Reid | A. Buxton | K. Janeway | R. Gorlick | M. Krailo | V. Villalobos | J. Moscow | S. Malempati | J. Brenda | E. Crowley | Lisa M. Kopp | Yun-he Gao | Weigel | Thomas A. Hawthorne